Dimensional Fund Advisors
TXG icon

Dimensional Fund Advisors’s 10x Genomics TXG Stock Holding History

Dimensional Fund Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.3M Buy
2,225,284
+182,334
+9% +$4.78M 0.02% 1300
2026
Q1 		$43.4M Buy
2,042,950
+525,369
+35% +$10.5M 0.01% 1575
2025
Q4 		$24.8M Buy
1,517,581
+762,201
+101% +$11.5M 0.01% 1872
2025
Q3 		$8.83M Buy
755,380
+610,124
+420% +$7.96M ﹤0.01% 2345
2025
Q2 		$1.68M Buy
145,256
+15,109
+12% +$138K ﹤0.01% 2803
2025
Q1 		$1.14M Buy
130,147
+16,765
+15% +$211K ﹤0.01% 2854
2024
Q4 		$1.63M Sell
113,382
-23,956
-17% -$378K ﹤0.01% 2833
2024
Q3 		$3.1M Sell
137,338
-77,754
-36% -$1.61M ﹤0.01% 2670
2024
Q2 		$4.19M Sell
215,092
-261,145
-55% -$6.84M ﹤0.01% 2551
2024
Q1 		$17.9M Sell
476,237
-25,177
-5% -$1.11M ﹤0.01% 2048
2023
Q4 		$28.1M Sell
501,414
-2,211
-0.4% -$96.2K 0.01% 1813
2023
Q3 		$20.8M Buy
503,625
+297,818
+145% +$15.5M 0.01% 1899
2023
Q2 		$11.5M Buy
205,807
+176,752
+608% +$9.57M ﹤0.01% 2194
2023
Q1 		$1.62M Buy
29,055
+18,488
+175% +$863K ﹤0.01% 2788
2022
Q4 		$385 Sell
10,567
-2,639
-20% -$86.3K ﹤0.01% 3089
2022
Q3 		$377K Sell
13,206
-20,130
-60% -$767K ﹤0.01% 3104
2022
Q2 		$1.51M Sell
33,336
-44,392
-57% -$2.3M ﹤0.01% 2823
2022
Q1 		$5.91M Buy
77,728
+11,731
+18% +$1.03M ﹤0.01% 2488
2021
Q4 		$9.83M Buy
65,997
+1,732
+3% +$265K ﹤0.01% 2316
2021
Q3 		$9.36M Buy
64,265
+3,378
+6% +$580K ﹤0.01% 2359
2021
Q2 		$11.9M Buy
60,887
+27,941
+85% +$5.06M ﹤0.01% 2280
2021
Q1 		$5.96M Buy
32,946
+19,324
+142% +$3.34M ﹤0.01% 2514
2020
Q4 		$1.93M Buy
13,622
+7,671
+129% +$1.11M ﹤0.01% 2819
2020
Q3 		$742K Buy
+5,951
New +$625K ﹤0.01% 2994

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors's TXG Position: Q2 2026 in Review

Dimensional Fund Advisors increased its 10x Genomics (TXG) stake by 8.9% in Q2 2026, buying an estimated $4.78M and bringing the position to 2,225,284 shares worth $85.3M. The position accounts for 0.02% of the portfolio, ranked #1300.

Dimensional Fund Advisors first reported a position in TXG in Q3 2020 and has held it in 24 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Dimensional Fund Advisors held 2,225,284 shares of 10x Genomics worth $85.3M as of Q2 2026.
  • Dimensional Fund Advisors bought 182,334 10x Genomics shares in Q2 2026, an estimated $4.78M.
  • 10x Genomics made up 0.02% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1300 holding.
  • Dimensional Fund Advisors first reported a position in 10x Genomics in Q3 2020 and has held it in 24 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.